What is the current Price Target for the Sorrento Therapeutics, Inc. stock?

The average Sorrento Therapeutics, Inc. target price is $13.26. This is 662,900.00% higher than the current stock price. The highest price target is 682,400.00%, the lowest is 656,400.00%. 3 Analysts have issued a price target Sorrento Therapeutics, Inc. 2026 .

How high will the Sorrento Therapeutics, Inc. stock rise?

No reliable answer can be given as to how high the Sorrento Therapeutics, Inc. stock will rise. The performance of stocks, including the Sorrento Therapeutics, Inc. stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Sorrento Therapeutics, Inc. stock today?

The performance of Sorrento Therapeutics, Inc. stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Sorrento Therapeutics, Inc. stock fall?

The decline in Sorrento Therapeutics, Inc. stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Sorrento Therapeutics, Inc. Forecast, price target & analysts

$0.00

0.00% yesterday

Nasdaq, Aug 11, 09:51 pm CET

ISIN

US83587F2020

Symbol

SRNE

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Dividends Analysts Charts Strategies

Sorrento Therapeutics, Inc. Target price 2025 - Analyst rating & recommendation

Sorrento Therapeutics, Inc. Classifications & Recommendation:

Buy

86%

Hold

14%

Sorrento Therapeutics, Inc. Price Target

Target Price	$13.26
Price	$0.00
Potential	662,900.00% register free of charge
Number of Estimates	3

	3 Analysts have issued a price target Sorrento Therapeutics, Inc. 2026 . The average Sorrento Therapeutics, Inc. target price is $13.26. This is 662,900.00% register free of charge higher than the current stock price. The highest price target is $13.65 682,400.00% register free of charge , the lowest is $13.13 656,400.00% register free of charge .
	A rating was issued by 7 analysts: 6 Analysts recommend Sorrento Therapeutics, Inc. to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Sorrento Therapeutics, Inc. stock has an average upside potential 2026 of 662,900.00% register free of charge . Most analysts recommend the Sorrento Therapeutics, Inc. stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2023, 2024 & 2025

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '22	2023 Estimates
Earnings Per Share $	-1.37	-0.69
	5.52%	49.64%
P/E		0.00
EV/Sales		1.06

Based on analysts' sales estimates for 2023, the Sorrento Therapeutics, Inc. stock is valued at an EV/Sales of

Unlock

and an P/S ratio of

Unlock

This results in the following potential growth metrics and future valuations:

Current	0.97	5.83%
2023	1.06 9.51% Unlock
2024	0.29 72.69% Unlock
2025	0.15 48.36% Unlock

Current	0.02	75.94%
2023	0.01 9.30% Unlock
2024	0.00 72.34% Unlock
2025	0.00 48.72% Unlock

Sorrento Therapeutics, Inc....

Discover more stocks with a high price target

Deutsche Telekom 29.37%

BioNTech SE - ADR 28.36%

Alibaba Group Holding Ltd 27.69%

PayPal 25.45%

Walt Disney 22.35%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now